Oric Pharmaceuticals, Inc. (ORIC) Form 10-K Annual Reports
Oric Pharmaceuticals, Inc. (ORIC) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ORIC
CIK: 1796280
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerGerald Schemidt
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-02 | 2026-10-01 | 4 Filing | 0001584759-26-000017 | View SEC Doc Filr Page |
| 144 | 2026-10-01 | — | 144 Filing | 0001968582-26-001030 | View SEC Doc Filr Page |
| 144 | 2026-10-01 | — | 144 Filing | 0001968582-26-001029 | View SEC Doc Filr Page |
| 4 | 2026-09-29 | 2026-09-28 | 4 Filing | 0001695028-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-24 | 4 Filing | 0001695028-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-08-28 | 2026-08-26 | 4 Filing | 0001695028-26-000006 | View SEC Doc Filr Page |
| 144 | 2026-08-26 | — | 144 Filing | 0001968582-26-000883 | View SEC Doc Filr Page |
| 10-Q | 2026-08-03 | 2026-06-30 | 10-Q | 0001193125-26-330631 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K | 0001193125-26-330568 | View SEC Doc Filr Page |
| S-8 | 2026-07-30 | — | S-8 | 0001193125-26-326363 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-28 | 8-K | 0001193125-26-326309 | View SEC Doc Filr Page |
| 4 | 2026-07-28 | 2026-07-24 | 4 Filing | 0001584759-26-000015 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-06 | 4 Filing | 0001584759-26-000012 | View SEC Doc Filr Page |
| 144 | 2026-07-06 | — | 144 Filing | 0001968582-26-000699 | View SEC Doc Filr Page |
| 144 | 2026-07-06 | — | 144 Filing | 0001968582-26-000698 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-18 | 8-K | 0001193125-26-277511 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000905148-26-002430 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001738048-26-000058 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000919574-26-003469 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0000080255-26-000420 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-12 | — | SCHEDULE 13G/A Filing | 0000078003-26-000067 | View SEC Doc Filr Page |
| 10-Q | 2026-05-04 | 2026-03-31 | 10-Q | 0001193125-26-204047 | View SEC Doc Filr Page |
| 8-K | 2026-05-04 | 2026-05-04 | 8-K | 0001193125-26-203993 | View SEC Doc Filr Page |
| ARS | 2026-04-28 | 2025-12-31 | ARS | 0001193125-26-186947 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-28 | — | DEFA14A | 0001193125-26-186921 | View SEC Doc Filr Page |